Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China flag China · Delayed Price · Currency is CNY
14.75
-0.30 (-1.99%)
Nov 18, 2026, 3:00 PM CST

SHA:600671 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
36.3931.8965.7297.9642.3922.29
Cash & Short-Term Investments
36.3931.8965.7297.9642.3922.29
Cash Growth
209.94%-51.48%-32.91%131.09%90.18%194.31%
Accounts Receivable
131.27146.6997.9736.9630.9951.83
Other Receivables
1.631.342.5621.7954.92
Receivables
132.89148.03100.5438.9632.78106.75
Inventory
35.5239.1852.3242.9547.5652.36
Prepaid Expenses
----0.03-
Other Current Assets
10.019.374.131.631.374.68
Total Current Assets
214.82228.48222.71181.5124.13186.08
Property, Plant & Equipment
189.28193.85192.86151.66164.94199.82
Goodwill
1.611.611.612.22.23.31
Other Intangible Assets
4.895.015.095.215.375.52
Long-Term Deferred Tax Assets
7.879.867.143.513.451.98
Long-Term Deferred Charges
2.873.1612.052.22.485.93
Other Long-Term Assets
0.060.06----
Total Assets
421.4442.03441.46346.29302.57402.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
72.1760.7558.3544.7135.9248.97
Accrued Expenses
3.7512.6414.2412.615.1313.92
Short-Term Debt
144.6144.3128.91102.94105.14108.15
Current Portion of Long-Term Debt
3.22-----
Current Portion of Leases
-12.8413.114.443.441
Current Income Taxes Payable
8.234.3910.443.020.30.66
Current Unearned Revenue
3.733.352.453.393.582.99
Other Current Liabilities
23.8244.1658.8849.2857.7175.45
Total Current Liabilities
259.51282.42286.38220.38221.22251.15
Long-Term Leases
11.088.6510.347.237.464.55
Long-Term Unearned Revenue
42.2246.6552.6358.6265.2578.71
Long-Term Deferred Tax Liabilities
5.857.966.142.972.65-
Other Long-Term Liabilities
2.152.360.951.151.433.68
Total Liabilities
320.81348.04356.44290.34298.01338.09

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
121.78121.78121.78121.78121.78121.78
Additional Paid-In Capital
162.79162.79162.79162.7972.7965.04
Retained Earnings
-206.45-214.56-232.18-247.43-209.15-141.63
Total Common Equity
78.1170.0152.3837.14-14.5945.18
Minority Interest
22.4723.9932.6418.8119.1519.37
Shareholders' Equity
100.5993.9985.0255.954.5664.56
Total Liabilities & Equity
421.4442.03441.46346.29302.57402.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
158.9165.79152.35114.61116.04113.7
Net Cash (Debt)
-122.51-133.91-86.63-16.65-73.65-91.41
Net Cash Growth
------
Net Cash Per Share
-1.01-1.10-0.71-0.14-0.60-0.74
Filing Date Shares Outstanding
121.81121.78121.78121.78121.78121.78
Total Common Shares Outstanding
121.81121.78121.78121.78121.78121.78
Working Capital
-44.69-53.95-63.67-38.88-97.09-65.08
Book Value Per Share
0.640.570.430.30-0.120.37
Tangible Book Value
71.6163.3845.6829.72-22.1636.34
Tangible Book Value Per Share
0.590.520.380.24-0.180.30
Buildings
-107.1107.1107.1107.1117.62
Machinery
-140.38141.27103.57109117.51
Construction In Progress
-18.111.250.020.118.62